SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Eros International Plc of Class Action Lawsuit and a Lead Plaintiff Deadline of January 12, 2016 – EROS

NEW YORK, Dec. 01, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Eros International plc (“Eros”) (NYSE: EROS ) between June 17, 2014 and October 30, 2015 .     

You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the District of New Jersey. If you purchased or otherwise acquired Eros International between June 17, 2014 and October 30, 2015, your rights may be affected by this action. To get more information go to :

http://zlk.9nl.com/eros-international

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

According to the complaint, throughout the Class Period defendants issued materially false and misleading statements to investors and/or failed to disclose that: (i) the Company’s reported earnings significantly overstated the economic viability of Eros’s business model; (ii) the Company’s accounting policy for amortization was unjustifiably aggressive in light of the impact of piracy on the long-term value of Eros’s assets; (iii) despite the Company’s reported profitability, Eros generates no cash; (iv) Eros has only been able to stay afloat by issuing stock and taking on debt; (v) Eros significantly overstated the number of movies the Company distributed and the Company’s theatrical revenues during fiscal years 2014 and 2015; and (vi) as a result of the foregoing, Eros’s public statements were materially false and misleading at all relevant times.

If you suffered a loss in Eros you have until January 12, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

Levi & Korsinsky, LLP Joseph E. Levi, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jade Power Trust Celebrates Success at Annual and Special Meeting

Updated Category News Views 190

Jade Power Trust's Annual Meeting Highlights Jade Power Trust (TSXV: JPWR.H) recently concluded its Annual and Special Meeting of unitholders, where significant decisions were made to shape the future of the Trust. The meeting, organized with great attention and resources, took place with a focus on transparency and community engagement. Re-election of Board Members...

Continue Reading
Vesper Bio's Breakthrough Phase I Results for FTD Treatment

Updated Category News Views 112

Vesper Bio Reports Positive Results from Phase I Study Vesper Bio ApS, a biotech company in the clinical stage known for its advancements in sortilin receptor biology, has made significant strides with its lead candidate, VES001. This groundbreaking compound is emerging as a potentially disease-modifying treatment for patients diagnosed with frontotemporal dementia (FTD),...

Continue Reading
Texas Pacific Land Trust Achieves Record Stock Performance

Updated Category News Views 103

Texas Pacific Land Trust Reaches New Heights In a significant display of market strength, Texas Pacific Land Trust (NYSE: TPL) stock has soared to an extraordinary all-time high of $996.82. This remarkable feat highlights a period of impressive growth for the company, as its stock has demonstrated a stunning 63.04% increase over the past year. Investors are exhibiting...

Continue Reading
Headwall Photonics Partners with NV5 to Enhance ENVI Software

Updated Category News Views 77

Headwall Photonics scored a major win back in 2024, announcing a strategic partnership with NV5 that aimed to shake up the hyperspectral imaging landscape. The deal wasn’t just about another tech tie-up; it was about embedding NV5's renowned ENVI software into Headwall's offerings, which could change how users handle geospatial data. ENVI Software Integration: What’s...

Continue Reading
DZS Inc. Completes Strategic Asset Sale to AXON Networks

Updated Category News Views 222

DZS Inc. Completes Strategic Asset Sale DZS Inc. (OTC: DZSI), known for its advanced network edge, connectivity, and cloud edge software solutions, has successfully completed the sale of its service assurance and WiFi management software portfolio to AXON Networks. This transaction includes key products such as Expresse, CloudCheck, and TruSpeed, along with their...

Continue Reading